Abstract
Background There is growing recognition that tuberculosis (TB) infection and disease exists as a spectrum of states beyond the current binary classification of latent and active TB. Our aim was to systematically map and synthesize published conceptual frameworks for different TB states from the literature.
Methods We searched MEDLINE, Embase and EMcare for systematic and narrative reviews without date restrictions. We included articles that explicitly described greater than two states for TB. We conducted a thematic and frequency analysis for terminologies, conceptual definitions and diagnostic criteria for defined TB states.
Results We identified 37 articles that met our inclusion criteria. All included articles were published after 2009. We identified eight broad conceptual themes that were used to categorize TB states and to calculate their frequency among included articles. These states were: State 0: Mycobacterium tuberculosis (Mtb) elimination by innate immune response (n=23/37, 62%); State I: Mtb elimination by acquired immune response (n=28/37, 76%); State II: Mtb infection not eliminated but controlled by immune system (n=34/37, 92%); State III: Mtb infection not controlled by the immune system (n=21/37, 57%); State IV: bacteriologically positive without symptoms (n=23/37, 62%); State V: signs or symptoms associated with TB (n=36/37, 97%); State VI: severe or disseminated TB disease (n=11/37, 30%); and State VII: previous history of TB (n=5/37, 14%). We found 27 additional variations within these themes that were labelled as “sub-states.” Articles varied in the terminology used to describe conceptual states and similar terms were often used to describe different concepts. Diagnostic criteria were provided in 27 articles and were also applied inconsistently.
Conclusion Terminologies and definitions for TB states are highly inconsistent in the literature. Consensus on a framework that includes additional TB states is required to standardize communication in scientific publications as well as to inform advancements in research, clinical and public health practice.
Evidence before this study The current paradigm of tuberculosis (TB) is based on a binary classification into “latent” infection and “active” disease states. In recent years, there has been growing recognition that this binary classification does not accurately reflect the complex pathophysiology of the disease process and that it may also be inadequate for informing research and programmatic advances for global TB elimination. While a number of articles have proposed multiple states of infection and disease, no previous study has mapped and synthesized evidence from published literature to inform an overarching and inclusive staging framework. We conducted a comprehensive search on MEDLINE, Embase and EMCare databases for systematic or narrative review articles or commentaries with terms related to TB and “states”, “stages,” “paradigm” “framework” or “spectrum” without date restrictions. We included 37 articles that explicitly described TB as a multi-state, i.e., beyond latent and active disease.
Added value of this study To our knowledge, this is the first study to systematically review conceptual frameworks, terminologies and diagnostic criteria for TB states beyond the latent and active paradigm. We identified that there is substantial variation in the number of TB states described in the literature, as well as in the concepts used to categorize them. Terms used for describing TB states and their diagnostic criteria were also inconsistently applied.
Implications of all the available evidence Our review highlights the need for a clear consensus on the overall conceptual framework, terminology and diagnostic criteria for TB states. The inconsistency in TB states among articles included in our review reflects diverse perspectives, academic interests and research priorities. The consensus process should therefore aim to be inclusive so that a proposed framework can be acceptable to a broad range of stakeholders including clinicians, researchers, public health and policy practitioners, as well as to individuals living with or with experience of TB.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was partially funded by a UKRI MRC grant (MR/V00476X/1) awarded to HE. HE is partially supported through MRC unit grants (MC UU 00004/04). SMAZ is supported through the Commonwealth Scholarship Commission (PKCS 2022-393). AKC is supported by NHMRC (GNT2020750) and WEHI. RMGJH is supported by the European Research Council (Action Number 757699)
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
